Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells

[1]  W R Mayr,et al.  Nomenclature for factors of the HLA system, 2000. , 2001, Human immunology.

[2]  X. N. Wang,et al.  T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation. , 2000, Transplantation.

[3]  M. Chopek,et al.  The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor–recipient pairs , 2000, Bone Marrow Transplantation.

[4]  Anajane G. Smith,et al.  Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. , 1999, Blood.

[5]  J. Hansen,et al.  Effect of HLA mismatches on the outcome of hematopoietic transplants. , 1999, Current opinion in immunology.

[6]  P. Noris,et al.  Incompatibility for CD31 and human platelet antigens and acute graft‐versus‐host disease after bone marrow transplantation , 1999, British journal of haematology.

[7]  J. McCluskey,et al.  Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation. , 1999, Human immunology.

[8]  M. Bunce,et al.  A DNA-based detection and screening system for identifying HLA class I expression variants by sequence-specific primers. , 1999, Tissue antigens.

[9]  G. Heller,et al.  HLA-C disparity between patients and unrelated donors matched for HLA-A, -B, and -DRB1 alleles: impact of serological vs. DNA typing for HLA-A and -B loci. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  M. Maiers,et al.  The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. , 1999, Human immunology.

[11]  I. Joosten,et al.  Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT , 1998, Bone Marrow Transplantation.

[12]  Anajane G. Smith,et al.  Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. , 1998, Blood.

[13]  C Anasetti,et al.  Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. , 1998, The New England journal of medicine.

[14]  F. Aversa,et al.  Use of stem cells from mismatched related donors , 1997, Current opinion in hematology.

[15]  G. Longton,et al.  Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation. , 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[16]  N. Schmitz,et al.  German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells , 1997, Bone Marrow Transplantation.

[17]  J. Hansen,et al.  Hematopoietic stem cell transplants from unrelated donors , 1997, Immunological reviews.

[18]  A. Gratwohl,et al.  Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) , 1997, Bone Marrow Transplantation.

[19]  R Storb,et al.  Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. , 1997, Blood.

[20]  P. Henslee-Downey,et al.  Use of partially mismatched related donors extends access to allogeneic marrow transplant. , 1997, Blood.

[21]  E. Goulmy,et al.  Minor histocompatibility antigens: from T cell recognition to peptide identification. , 1997, Human immunology.

[22]  G. Longton,et al.  Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. , 1997, Blood.

[23]  Loiseau,et al.  Does the Adhesion Molecule CD31 Act as a Minor Histocompatibility Antigen? , 1997, Blood.

[24]  G. Longton,et al.  Definition of HLA-DQ as a transplantation antigen. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Speiser,et al.  Pretransplant cytotoxic donor T‐cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT , 1996, British journal of haematology.

[26]  D. Speiser,et al.  High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. , 1996, Blood.

[27]  H. Sayer,et al.  Bone marrow transplantation from partially HLA‐matched related donors in adults with leukaemia: The Experience at the University Hospital of Essen, Germany , 1996, British journal of haematology.

[28]  J. Zehnder,et al.  Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. , 1996, The New England journal of medicine.

[29]  G. Longton,et al.  Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation. , 1996, Tissue antigens.

[30]  G. Longton,et al.  The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. , 1995, Blood.

[31]  S. Davies,et al.  Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome. , 1995, Blood.

[32]  H. Heimpel,et al.  Presence of host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graft-versus-host disease. , 1995, Bone marrow transplantation.

[33]  R. Lechler,et al.  COMPARISON OF HELPER AND CYTOTOXIC ANTIRECIPIENT T CELL FREQUENCIES IN UNRELATED BONE MARROW TRANSPLANTATION , 1994, Transplantation.

[34]  H. Grosse-wilde,et al.  Immunogenetic marrow donor search for 1012 patients: a retrospective analysis of strategies, outcome and costs. , 1994, Bone marrow transplantation.

[35]  D. Speiser,et al.  THE FREQUENCY OF PRETRANSPLANT DONOR CYTOTOXIC T CELL PRECURSORS WITH ANTI‐HOST SPECIFICITY PREDICTS SURVIVAL OF PATIENTS TRANSPLANTED WITH BONE MARROW FROM DONORS OTHER THAN HLA‐IDENTICAL SIBLINGS , 1993, Transplantation.

[36]  H. Bontkes,et al.  High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD. , 1993, Bone marrow transplantation.

[37]  G. Longton,et al.  The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. , 1993, Blood.

[38]  E. Goulmy,et al.  Human minor histocompatibility antigens. , 1993, Transplant immunology.

[39]  R. Lechler,et al.  Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation , 1993, The Lancet.

[40]  G. Longton,et al.  The Role of HLA-DPB 1 Disparity in the Development of Acute Graft-Versus-Host Disease Following Unrelated Donor Marrow Transplantation , 2003 .

[41]  H. Heimpel,et al.  Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. , 1992, The New England journal of medicine.

[42]  R. Storb,et al.  Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. , 1990, Human immunology.